|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 3442 | Drugs / Medical | 08/19/2004
The parties have reached a tentative settlement valued at $12,457,350 CDN in a class action filed against Bristol-Myers Squibb Canada Company and Bristol-Myers Squibb Company on behalf of all Canadian residents who purchased Stadol NS nasal spray in Canada from July 1, 1994, to July 1, 2004. The action alleged that the nasal spray is addictive and that the defendants did not adequately warn patients of the possibility of addiction. The court has apparently not yet set a claims deadline-- persons eligible to take part in the settlement should contact attorneys for the class as soon as possible.
Stadol is no longer being distributed into the Canadian market. Persons who used Stadol NS may obtain compensation based on how many bottles of the drug they purchased and what types of difficulty they experienced as a result of any dependence. The details of how payments will be calculated are laid out in the settlement notice that has been approved by the court. A preliminary copy of the notice may be viewed at the settlement web site. The Ontario Superior Court of Justice will determine if the settlement is in the best interests of class members in a proceeding scheduled for June 28, 2004. If the settlement is approved, further notice will be published giving Class members the option of filing a claim or opting-out of the settlement. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Drugs / Medical Cases of Interest A class action has been filed against pharmaceutical company Biovail Corporation (NYSE: BVF) and certain of its officers and directors by stockholders who purchased the company's common stock between May 17, 2002, and October 30, 2003. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. A class action has been filed against Dura Pharmaceuticals, Inc. (formerly Nasdaq: DURA) and certain of its officers and directors by stockholders who purchased the company's common stock between April 15, 1997, and February 24, 1998. Uninsured hospital patient Robert Honke filed a lawsuit against Alton Memorial Hospital in Madison County Circuit Court, Illinois. Honke claims AMH charged him more for services than for patients with health insurance.
According to the complaint, AMH was to only charge Honke reasonable and customary rates for healthcare services and he would only be obligated to pay reasonable charges for the services he received.
Kahn Gauthier Swick is investigating possible legal actions against EndoVascular Technologies, Inc., a wholly-owned subsidiary of medical device manufacturer Guidant Corporation, on behalf of persons who were implanted with EndoVascular's Ancure Endograft System, which is used to repair abdominal aorta aneurysms. Kahn Gauthier Swick is seeking persons who have used over-the-counter homeopathic nasal solutions Zicam or Cold-Eeze, and who have suffered an intense burning sensation in their nasal cavities immediately after using either of the products followed by a loss of smell and taste long after they were over their cold. If you or a loved one has used either of these preparations, please contact Kahn Gauthier for more information. The parties have reached a tentative $3.5 million settlement in an action filed against David E. Tremoglie, the HMO that employed him, its malpractice insurer, and related companies. The action alleged that Mr. Tremoglie masqueraded as a psychiatrist in violation of state and federal medical licensing regulations. Persons who were treated by Mr. Tremoglie should contact the attorneys for the class as soon as possible, to be able to participate in the settlement. |
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
